# XTL Biopharmaceuticals Ltd: Form 6-K, filed Mar 21, 2024

- Company: [XTL Biopharmaceuticals Ltd](/companies/xtlb.md) (CIK 1023549)
- Form: 6-K
- Filed: 2024-03-21
- Accepted by EDGAR: Mar 21, 2024, 20:31 ET
- Period: 2024-03-21
- Accession: 0001213900-24-024787
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1023549/000121390024024787/ea0202214-6k_xtlbio.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1023549/000121390024024787/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1023549/000121390024024787/ea0202214-6k_xtlbio.htm

Filed Mar 21, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-024787. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.